Evidence map›Paper›PMID 27787529›Full record

ArticleIntegrative biology : quantitative biosciences from nano to macro2016

Self-assembly of vascularized tissue to support tumor explants in vitro.

Despina Bazou, Nir Maimon, Gabriel Gruionu, Lance L Munn

Abstract read
In one paragraph

Article in Integrative biology : quantitative biosciences from nano to macro, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Advances and challenges in human 3D solid tumor models.Advanced functional materials · 2025
    Article
  4. Microfluidic Modulation of Microvasculature in Microdissected Tumors.bioRxiv : the preprint server for biology · 2024
    Article
  5. Making In Vitro Tumor Models Whole Again.Advanced healthcare materials · 2023
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Vascular beds maintain pancreatic tumour explants for ex vivo drug screening.Journal of tissue engineering and regenerative medicine · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Despina BazouEdwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, 100 Blossom Street, Boston, Massachusetts 02114, USA. munn@steele.mgh.harvard.edu.
Nir MaimonEdwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, 100 Blossom Street, Boston, Massachusetts 02114, USA. munn@steele.mgh.harvard.edu.
Gabriel GruionuDepartment of Surgery, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, Massachusetts 02114, USA.
Lance L MunnEdwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, 100 Blossom Street, Boston, Massachusetts 02114, USA. munn@steele.mgh.harvard.edu.

Funding

Systems biology of lymphatic transportR01HL128168 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MUNN, LANCE L., PADERA, TIMOTHY P · 2015 to 2019
$2.9M
Encouraging anastomosis of engrafted vascular networksR01HL106584 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MUNN, LANCE L. · 2012 to 2015
$1.3M
NHLBI NIH HHS R01 HL106584NHLBI NIH HHS R01 HL128168
6 · The paper itself

Abstract

Testing the efficacy of cancer drugs requires functional assays that recapitulate the cell populations, anatomy and biological responses of human tumors. Although current animal models and in vitro cell culture platforms are informative, they have significant shortcomings. Mouse models can reproduce tissue-level and systemic responses to tumor growth and treatments observed in humans, but xenografts from patients often do not grow, or require months to develop. On the other hand, current in vitro assays are useful for studying the molecular bases of tumorigenesis or drug activity, but often lack the appropriate in vivo cell heterogeneity and natural microenvironment. Therefore, there is a need for novel tools that allow rapid analysis of patient-derived tumors in a robust and representative microenvironment. We have developed methodology for maintaining harvested tumor tissue in vitro by placing them in a support bed with self-assembled stroma and vasculature. The harvested biopsy or tumor explant integrates with the stromal bed and vasculature, providing the correct extracellular matrix (collagen I, IV, fibronectin), associated stromal cells, and a lumenized vessel network. Our system provides a new tool that will allow ex vivo drug-screening and can be adapted for the guidance of patient-specific therapeutic strategies.

Indexed as

Tumor MicroenvironmentAnimalsBatch Cell Culture TechniquesHumansMiceNeoplasms, ExperimentalNeovascularization, PathologicTissue Culture TechniquesTumor Cells, Cultured

Identifiers

PMID27787529
PMCPMC5155578

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.